Abstract
Under diabetic conditions, oxidative stress is induced and the JNK pathway is activated, which is involved in deterioration of pancreatic β-cell function found in diabetes. Oxidative stress and/or activation of the JNK pathway suppress insulin gene expression, accompanied by reduction of PDX-1 DNA binding activity. Treatment with antioxidants and/or suppression of the JNK pathway protect β-cells from some of the toxic effects of hyperglycemia. The JNK pathway is also involved in the progression of insulin resistance; suppression of the JNK pathway in obese diabetic mice markedly improves insulin resistance and ameliorates glucose tolerance. The phosphorylation state of key molecules for insulin signaling is altered upon modification of the JNK pathway. Taken together, the JNK pathway plays a crucial role in progression of insulin resistance as well as β-cell dysfunction found in diabetes and thus could be a potential therapeutic target for diabetes.
Keywords: diabetic conditions, JNK pathway, insulin
Current Diabetes Reviews
Title: Oxidative Stress and the JNK Pathway in Diabetes
Volume: 1 Issue: 1
Author(s): Hideaki Kaneto, Taka-aki Matsuoka, Yoshihisa Nakatani, Dan Kawamori, Munehide Matsuhisa and Yoshimitsu Yamasaki
Affiliation:
Keywords: diabetic conditions, JNK pathway, insulin
Abstract: Under diabetic conditions, oxidative stress is induced and the JNK pathway is activated, which is involved in deterioration of pancreatic β-cell function found in diabetes. Oxidative stress and/or activation of the JNK pathway suppress insulin gene expression, accompanied by reduction of PDX-1 DNA binding activity. Treatment with antioxidants and/or suppression of the JNK pathway protect β-cells from some of the toxic effects of hyperglycemia. The JNK pathway is also involved in the progression of insulin resistance; suppression of the JNK pathway in obese diabetic mice markedly improves insulin resistance and ameliorates glucose tolerance. The phosphorylation state of key molecules for insulin signaling is altered upon modification of the JNK pathway. Taken together, the JNK pathway plays a crucial role in progression of insulin resistance as well as β-cell dysfunction found in diabetes and thus could be a potential therapeutic target for diabetes.
Export Options
About this article
Cite this article as:
Kaneto Hideaki, Matsuoka Taka-aki, Nakatani Yoshihisa, Kawamori Dan, Matsuhisa Munehide and Yamasaki Yoshimitsu, Oxidative Stress and the JNK Pathway in Diabetes, Current Diabetes Reviews 2005; 1 (1) . https://dx.doi.org/10.2174/1573399052952613
DOI https://dx.doi.org/10.2174/1573399052952613 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Pluripotential Effects of Hypolipidemic Treatment for Polycystic Ovary Syndrome (PCOS): Dyslipidemia, Cardiovascular Risk Factors and Beyond
Current Pharmaceutical Design Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
Current Cancer Drug Targets The PIK3CA Gene as a Mutated Target for Cancer Therapy
Current Cancer Drug Targets Can the Use of HIV-1 Derived Gene Transfer Vectors for Clinical Application be Justified?
Current Gene Therapy Sample Size Estimation for Negative Binomial Regression Models with Distinct Shape Parameters
Applied Clinical Research, Clinical Trials and Regulatory Affairs Endocrine Disrupting Chemical Induced “Pollution of Metabolic Pathways”: A Case of Shifting Paradigms With Implications for Vascular Diseases
Current Drug Targets Phenylbutyric Acid: Simple Structure - Multiple Effects
Current Pharmaceutical Design Physical Activity-Induced Improvements in Markers of Insulin Resistance in Overweight and Obese Children and Adolescents
Current Diabetes Reviews Drug Development from Natural Resource: A Systematic Approach
Mini-Reviews in Medicinal Chemistry Pancreatic Islets Under Attack: Cellular and Molecular Effectors
Current Pharmaceutical Design Sodium-glucose Cotransporter 2 Inhibitors: The Pleiotropic Mechanisms of Actions
Cardiovascular & Hematological Disorders-Drug Targets New Development and Application of Ultrasound Targeted Microbubble Destruction in Gene Therapy and Drug Delivery
Current Gene Therapy Fibrates and Microvascular Complications in Diabetes - Insight from the FIELD Study
Current Pharmaceutical Design Therapy of Chronic Hepatitis C in the Era of Nanotechnology: Drug Delivery Systems and Liver Targeting
Mini-Reviews in Medicinal Chemistry Controlled Release of Insulin in Blood from Strontium-Substituted Carbonate Apatite Complexes
Current Drug Delivery PDE5 Inhibitors in Non-Urological Conditions
Current Pharmaceutical Design Metabolic Therapy of Heart Failure
Current Pharmaceutical Design Recent Development and Future Prospects of Plant-Based Vaccines
Current Drug Metabolism Current Concepts in Gastric Motility in Diabetes Mellitus
Current Diabetes Reviews Editorial (Hot Topic: New Insight into the RAMP-based Family B GPCRs and their Peptide Ligands)
Current Protein & Peptide Science